市場調査レポート
商品コード
1370224
臨床試験用品市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測Clinical Trial Supplies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
臨床試験用品市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測 |
出版日: 2023年10月15日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2~3営業日
|
世界の臨床試験用品市場規模は2022年に23億米ドルに達しました。今後、IMARC Groupは、2023年から2028年にかけて7.4%の成長率(CAGR)を示し、2028年には36億米ドルに達すると予測しています。
臨床試験用品とは、科学的実験や調査、臨床研究を実施するために使用される様々なツールや機器を指します。輸液ポンプ、ネブライザー、注射針は最も一般的に使用される臨床試験用品です。これらは主に、様々な病気の発見、予防、治療、治療法の効率分析、様々な感染症や代謝性疾患の診断のための医療試験を実施するために使用されます。また、呼吸器、腫瘍、心臓血管、神経学的処置の際にも幅広く使用されています。
バイオ医薬品業界の著しい成長は、市場の成長を促す重要な要因のひとつです。臨床試験は、革新的なドラッグデリバリーシステムの開発とともに、HIVやがんなどの疾患の治療において絶大な支持を得ています。さらに、コールドチェーン・ロジスティクスやモニタリング技術の開発を促進する技術の進歩も、重要な成長促進要因となっています。製品メーカーは、無駄を最小限に抑え、全体的なコスト効率を高める生産・包装プロセスの最適化に注力しています。さらに、委託研究機関(CRO)の新たな動向も市場成長にプラスの影響を与えています。CROは、製薬、バイオテクノロジー、医療機器メーカーが契約ベースで研究活動を外注することを可能にし、それによって様々な試験用品の利用を増加させる。その他にも、先進的な医薬品や治療法の開発のために政府機関や非政府組織(NGO)の両方が行っている広範な研究開発(R&D)などがあり、市場の見通しは明るいと予想されます。
The global clinical trial supplies market size reached US$ 2.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.6 Billion by 2028, exhibiting a growth rate (CAGR) of 7.4% during 2023-2028.
Clinical trial supplies refer to various tools and equipment that are used for conducting scientific experiments, investigations and clinical research. Infusion pumps, nebulizers and syringe needles are the most commonly used clinical trial supplies. They are primarily used for conducting medical trials for detecting, preventing and treating various ailments, analyzing the efficiency of a treatment method, and in the diagnosis of various infectious and metabolic disorders. They also find extensive applications during respiratory, oncological, cardiovascular and neurological procedures.
Significant growth in the biopharmaceutical industry is one of the key factors driving the growth of the market. Clinical trials are gaining immense traction for treating diseases, such as HIV and cancer, along with the development of innovative drug delivery systems. Furthermore, technological advancements facilitating the development of cold chain logistics and monitoring technologies, are also acting as crucial growth-inducing factors. Product manufacturers are focusing on optimizing the production and packaging processes that can minimize wastage and enhance the overall cost-efficiency. Moreover, the emerging trend of contract research organizations (CROs) is also impacting the market growth positively. CROs enable the pharmaceutical, biotechnological and medical instrument manufacturers to outsource research activities on a contractual basis, thereby increasing the utilization of various trial supplies. Other factors, including extensive research and development (R&D) undertaken by both the governmental and non-governmental organizations (NGOs) for the development of advanced drugs and treatment methods, are expected to create a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global clinical trial supplies market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on services, phase, therapeutic area, and end-use industry.
Product Manufacturing
Packaging, Labeling and Storage
Logistics and Distribution
Based on the services, the market has been segmented into product manufacturing; packaging, labeling and storage; and logistics and distribution.
Phase I
Phase II
Phase III
Others
On the basis of the phase, the market has been segregated into phase I, phase II, phase III and others. At present, phase III exhibits a clear dominance in the market.
Oncology
Cardiovascular Diseases
Respiratory Diseases
CNS And Mental Disorders
Others
The market has been analyzed on the basis of the therapeutic area into oncology, cardiovascular diseases, respiratory diseases, central nervous system (CNS) and mental disorders, and others. Amongst these, oncology holds the largest market share.
Medical Device Industry
Biopharmaceuticals Industry
Pharmaceuticals Industry
Others
Based on the end-use industry, the market has been divided into medical devices, biopharmaceuticals, pharmaceuticals and others. Pharmaceuticals account for the majority of the total market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
On the geographical front, the market has been classified into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others); Europe (the United Kingdom, Germany, France, Italy, Spain, Russia and others); Latin America (Brazil, Mexico and others); and Middle East and Africa. Currently, North America enjoys the leading position in the market.
The report has also analysed the competitive landscape of the market with some of the key players being Almac Group Ltd., Catalent Pharma Solutions Inc., DHL, Parexel, Thermo Fisher Scientific Inc., PCI Services, Sharp Clinical, Biocair, Movianto, etc.